首页 > 最新文献

Oral Oncology Reports最新文献

英文 中文
Dysphagia as a primary predictor of malnutrition in head and neck cancer: Psychometric validation and diagnostic accuracy of the Greek MDADI 吞咽困难作为头颈癌营养不良的主要预测因素:希腊mddi的心理测量验证和诊断准确性
Pub Date : 2026-06-01 DOI: 10.1016/j.oor.2026.100789
Soultana Papadopoulou , Kalliopi Megari , Efrosyni Paparouna , Sotiria Styliani Moskofidou , Maria Theodoratou , Avraam Ploumis

Objectives

To assess the synergistic impact of radiotherapy-induced xerostomia and dysphagia on malnutrition in Greek Head and Neck Cancer (HNC) survivors compared with matched controls, and to psychometrically validate the Greek version of the MD Anderson Dysphagia Inventory (MDADI).

Materials and methods

A cross-sectional, case-control study was conducted with 66 HNC patients (3 months post-RT) and 67 age- and sex-matched healthy controls (Oct 2024–Apr 2025). The study adhered to STROBE guidelines (Ethics No. 37871). Participants completed the MDADI, Xerostomia Inventory (XI), and PG-SGA Short Form. Statistical analyses included Cronbach's alpha for validation, Mann–Whitney U tests, Spearman's ρ, multivariable logistic regression, and Receiver Operating Characteristic (ROC) curve analysis to determine diagnostic accuracy.

Results

The Greek MDADI demonstrated excellent internal consistency (α = 0.92) and discriminant validity (Patients: 61.0 vs. Controls: 83.0, p < 0.001). Xerostomia and dysphagia were highly prevalent and strongly correlated (ρ = −0.69, p < 0.001). In the multivariable model, dysphagia emerged as the sole independent predictor of malnutrition (OR = 0.86, 95% CI: 0.77–0.95, p = 0.004), indicating a 14% risk reduction for every 1-point improvement in MDADI. ROC analysis identified an MDADI score of <53 as the optimal cutoff for detecting malnutrition risk (AUC = 0.78, Sensitivity 55%, Specificity 93%).

Conclusions

Dysphagia is the primary driver of malnutrition in the early post-RT period. The Greek MDADI is a valid clinical tool, and a score below 53 should serve as a "red flag" triggering immediate nutritional and speech-pathology intervention. Integrated management of the xerostomia-dysphagia-malnutrition cluster is essential for survivorship care.
目的评估放疗引起的口干和吞咽困难对希腊头颈癌(HNC)幸存者营养不良的协同影响,并对希腊版MD安德森吞咽困难量表(mdadii)进行心理计量学验证。材料与方法对66例HNC患者(放疗后3个月)和67例年龄和性别匹配的健康对照(2024年10月- 2025年4月)进行横断面病例对照研究。该研究遵循STROBE指南(伦理第37871号)。参与者完成了MDADI、口干量表(XI)和PG-SGA短表。统计分析包括Cronbach’s alpha检验、Mann-Whitney U检验、Spearman’s ρ检验、多变量logistic回归和受试者工作特征(ROC)曲线分析来确定诊断准确性。结果希腊MDADI具有良好的内部一致性(α = 0.92)和判别效度(患者:61.0 vs.对照组:83.0,p <; 0.001)。口干和吞咽困难非常普遍,且相关性很强(ρ = −0.69,p <; 0.001)。在多变量模型中,吞咽困难成为营养不良的唯一独立预测因子(OR = 0.86,95% CI: 0.77-0.95, p = 0.004),表明MDADI每改善1分,风险降低14%。ROC分析确定MDADI得分为53是检测营养不良风险的最佳截止值(AUC = 0.78,灵敏度55%,特异性93%)。结论吞咽困难是术后早期营养不良的主要驱动因素。希腊mddi是一种有效的临床工具,分数低于53分应作为“危险信号”,立即触发营养和语言病理学干预。综合管理口干-吞咽困难-营养不良集群是必不可少的生存护理。
{"title":"Dysphagia as a primary predictor of malnutrition in head and neck cancer: Psychometric validation and diagnostic accuracy of the Greek MDADI","authors":"Soultana Papadopoulou ,&nbsp;Kalliopi Megari ,&nbsp;Efrosyni Paparouna ,&nbsp;Sotiria Styliani Moskofidou ,&nbsp;Maria Theodoratou ,&nbsp;Avraam Ploumis","doi":"10.1016/j.oor.2026.100789","DOIUrl":"10.1016/j.oor.2026.100789","url":null,"abstract":"<div><h3>Objectives</h3><div>To assess the synergistic impact of radiotherapy-induced xerostomia and dysphagia on malnutrition in Greek Head and Neck Cancer (HNC) survivors compared with matched controls, and to psychometrically validate the Greek version of the MD Anderson Dysphagia Inventory (MDADI).</div></div><div><h3>Materials and methods</h3><div>A cross-sectional, case-control study was conducted with 66 HNC patients (3 months post-RT) and 67 age- and sex-matched healthy controls (Oct 2024–Apr 2025). The study adhered to STROBE guidelines (Ethics No. 37871). Participants completed the MDADI, Xerostomia Inventory (XI), and PG-SGA Short Form. Statistical analyses included Cronbach's alpha for validation, Mann–Whitney U tests, Spearman's ρ, multivariable logistic regression, and Receiver Operating Characteristic (ROC) curve analysis to determine diagnostic accuracy.</div></div><div><h3>Results</h3><div>The Greek MDADI demonstrated excellent internal consistency (α = 0.92) and discriminant validity (Patients: 61.0 vs. Controls: 83.0, p &lt; 0.001). Xerostomia and dysphagia were highly prevalent and strongly correlated (ρ = −0.69, p &lt; 0.001). In the multivariable model, dysphagia emerged as the sole independent predictor of malnutrition (OR = 0.86, 95% CI: 0.77–0.95, p = 0.004), indicating a 14% risk reduction for every 1-point improvement in MDADI. ROC analysis identified an MDADI score of &lt;53 as the optimal cutoff for detecting malnutrition risk (AUC = 0.78, Sensitivity 55%, Specificity 93%).</div></div><div><h3>Conclusions</h3><div>Dysphagia is the primary driver of malnutrition in the early post-RT period. The Greek MDADI is a valid clinical tool, and a score below 53 should serve as a \"red flag\" triggering immediate nutritional and speech-pathology intervention. Integrated management of the xerostomia-dysphagia-malnutrition cluster is essential for survivorship care.</div></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":"18 ","pages":"Article 100789"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148184691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship of worst pattern of invasion (WPOI) with clinicopathological parameters: A retrospective cohort study 最坏侵袭模式(WPOI)与临床病理参数的关系:回顾性队列研究
Pub Date : 2026-06-01 Epub Date: 2026-05-26 DOI: 10.1016/j.oor.2026.100788
Othman Mounbahij , Faiçal Slimani

Rationale and objective

The worst pattern of invasion (WPOI) has been in the last few years a highly studied pathological parameter. There is a clear trend of non-cohesive WPOI (4-5) to be highly aggressive and to affect outcomes negatively. The aim of this study was to investigate the link between WPOI and other clinicopathological parameters which are the lymph node metastasis (LNM), depth of invasion (DOI) and tumor size (TS).

Methods

This was a retrospective cohort study. The patients enrolled in the study were diagnosed with oral squamous cell carcinoma (OSCC) and underwent treatment at the Department of Stomatology, Oral and Maxillofacial Surgery at University Hospital Ibn Rochd (CHU 20th August). The exposure variable was the Worst Pattern of Invasion (WPOI) The outcome variables were LNM, DOI and TS. All statistical analysis was conducted using JASP version 0.19.3.0.

Results

A total of 33 patients were included in the study. The mean age was 65.1 years and the sample showed a clear male predominance. The relationship between WPOI and LNM was examined using a chi-squared test. Among patients with non-cohesive WPOI, 6 out of 13 (46.2%) had LNM, compared to 4 out of 20 (20%) in the cohesive WPOI group. Although the percentage of LNM was higher in the non-cohesive group, this difference was not statistically significant (X2(1) = 2.552,p = 0.110). An independent samples t-test was performed to assess the relationship between WPOI and DOI. The mean DOI was greater in the non-cohesive group (12.54 mm, SD = 8.09 mm) compared to the cohesive group (8.80 mm, SD = 5.69 mm). This difference, however, was not statistically significant (t(31) = −1.562,p = 0.129). The relationship between WPOI and TS was analyzed using an independent samples t-test. Interestingly, the mean TS was larger in the cohesive group (42.60 mm, SD = 26.39 mm) than in the non-cohesive group (32.08 mm, SD = 10.63 mm). This difference was also not statistically significant (t(31) = 1.361,p = 0.183).

Conclusion

Although the results weren't statistically significant, they should be put into the broader context of the study sample size of (n = 33). The higher incidence of LNM and higher DOI in the non-cohesive group (types 4-5) is in line with the strong correlation found in the literature. Our results, while not statistically significant, corroborate the established link between non-cohesive WPOI and more aggressive disease.
基本原理和目的近年来,最坏浸润模式(WPOI)一直是一个被高度研究的病理参数。非内聚性WPOI(4-5)明显倾向于具有高度侵略性,并对结果产生负面影响。本研究旨在探讨WPOI与淋巴结转移(LNM)、浸润深度(DOI)和肿瘤大小(TS)等其他临床病理参数的关系。方法回顾性队列研究。入选研究的患者被诊断为口腔鳞状细胞癌(OSCC),并于8月20日在伊本罗克德大学医院口腔颌面外科接受治疗。暴露变量为最坏入侵模式(Worst Pattern of Invasion, WPOI),结局变量为LNM、DOI和TS,采用JASP 0.19.3.0版本进行统计分析。结果共纳入33例患者。平均年龄为65.1岁,男性占明显优势。WPOI与LNM之间的关系采用卡方检验。在非内聚性WPOI患者中,13人中有6人(46.2%)患有LNM,而内聚性WPOI组中20人中有4人(20%)患有LNM。虽然非凝聚力组的LNM百分比较高,但差异无统计学意义(X2(1) = 2.552,p = 0.110)。采用独立样本t检验评估WPOI和DOI之间的关系。非粘连组的平均DOI(12.54 mm, SD = 8.09 mm)大于粘连组(8.80 mm, SD = 5.69 mm)。然而,这种差异没有统计学意义(t(31) = −1.562,p = 0.129)。采用独立样本t检验分析WPOI与TS的关系。有趣的是,粘连组的TS平均值(42.60 mm, SD = 26.39 mm)大于非粘连组(32.08 mm, SD = 10.63 mm)。差异也无统计学意义(t(31) = 1.361,p = 0.183)。结论虽然结果不具有统计学意义,但应将其放在研究样本量(n = 33)的更大背景下考虑。非内聚组(4-5型)的LNM发生率较高,DOI也较高,这与文献中发现的强相关性一致。我们的结果虽然没有统计学意义,但证实了非内聚性WPOI与更具侵袭性疾病之间的既定联系。
{"title":"The relationship of worst pattern of invasion (WPOI) with clinicopathological parameters: A retrospective cohort study","authors":"Othman Mounbahij ,&nbsp;Faiçal Slimani","doi":"10.1016/j.oor.2026.100788","DOIUrl":"10.1016/j.oor.2026.100788","url":null,"abstract":"<div><h3>Rationale and objective</h3><div>The worst pattern of invasion (WPOI) has been in the last few years a highly studied pathological parameter. There is a clear trend of non-cohesive WPOI (4-5) to be highly aggressive and to affect outcomes negatively. The aim of this study was to investigate the link between WPOI and other clinicopathological parameters which are the lymph node metastasis (LNM), depth of invasion (DOI) and tumor size (TS).</div></div><div><h3>Methods</h3><div>This was a retrospective cohort study. The patients enrolled in the study were diagnosed with oral squamous cell carcinoma (OSCC) and underwent treatment at the Department of Stomatology, Oral and Maxillofacial Surgery at University Hospital Ibn Rochd (CHU 20th August). The exposure variable was the Worst Pattern of Invasion (WPOI) The outcome variables were LNM, DOI and TS. All statistical analysis was conducted using JASP version 0.19.3.0.</div></div><div><h3>Results</h3><div>A total of 33 patients were included in the study. The mean age was 65.1 years and the sample showed a clear male predominance. The relationship between WPOI and LNM was examined using a chi-squared test. Among patients with non-cohesive WPOI, 6 out of 13 (46.2%) had LNM, compared to 4 out of 20 (20%) in the cohesive WPOI group. Although the percentage of LNM was higher in the non-cohesive group, this difference was not statistically significant (X2(1) = 2.552,p = 0.110). An independent samples <em>t</em>-test was performed to assess the relationship between WPOI and DOI. The mean DOI was greater in the non-cohesive group (12.54 mm, SD = 8.09 mm) compared to the cohesive group (8.80 mm, SD = 5.69 mm). This difference, however, was not statistically significant (t(31) = −1.562,p = 0.129). The relationship between WPOI and TS was analyzed using an independent samples <em>t</em>-test. Interestingly, the mean TS was larger in the cohesive group (42.60 mm, SD = 26.39 mm) than in the non-cohesive group (32.08 mm, SD = 10.63 mm). This difference was also not statistically significant (t(31) = 1.361,p = 0.183).</div></div><div><h3>Conclusion</h3><div>Although the results weren't statistically significant, they should be put into the broader context of the study sample size of (n = 33). The higher incidence of LNM and higher DOI in the non-cohesive group (types 4-5) is in line with the strong correlation found in the literature. Our results, while not statistically significant, corroborate the established link between non-cohesive WPOI and more aggressive disease.</div></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":"18 ","pages":"Article 100788"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148167930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combining immunotherapy and AlphaFold to improve outcomes in oral squamous cell carcinoma (OSCC) treatment 联合免疫治疗和AlphaFold改善口腔鳞状细胞癌(OSCC)治疗的预后
Pub Date : 2026-03-01 Epub Date: 2026-01-28 DOI: 10.1016/j.oor.2026.100785
Lucas Alves da Mota Santana , Rajiv Gandhi Gopalsamy , Sasikumar Ponnusamy , Leandro Napier de Souza , Cleverson Luciano Trento , Wilton Mitsunari Takeshita , Lysandro Pinto Borges
{"title":"Combining immunotherapy and AlphaFold to improve outcomes in oral squamous cell carcinoma (OSCC) treatment","authors":"Lucas Alves da Mota Santana ,&nbsp;Rajiv Gandhi Gopalsamy ,&nbsp;Sasikumar Ponnusamy ,&nbsp;Leandro Napier de Souza ,&nbsp;Cleverson Luciano Trento ,&nbsp;Wilton Mitsunari Takeshita ,&nbsp;Lysandro Pinto Borges","doi":"10.1016/j.oor.2026.100785","DOIUrl":"10.1016/j.oor.2026.100785","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":"17 ","pages":"Article 100785"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence in oral cancer: a feasibility study informed by Freud's case 口腔癌中的人工智能:弗洛伊德案例的可行性研究
Pub Date : 2026-03-01 Epub Date: 2025-12-06 DOI: 10.1016/j.oor.2025.100773
Michael Truppe , Kurt Schicho , Michael Figl , Simone Holawe , Christos Perisanidis

Objective

To test whether a locally hosted, retrieval-augmented clinical decision framework (CDF) improves recognition of cocaine-induced midline destructive lesions (CIMDL)—a malignancy mimicker—during dental teleconsultation, compared with a cloud large language model (LLM) without retrieval.

Materials and methods

We conducted a paired feasibility evaluation using 401 simulated consultations derived from Sigmund Freud's historical lesion narrative. The local CDF used mistral-7b-instruct-v0.2 with retrieval-augmented generation (RAG) over a curated CIMDL corpus; the comparator was GPT-4o accessed without retrieval. Identical prompts and clinical context were used in both arms. The primary endpoint was inclusion of CIMDL in the differential diagnosis, adjudicated against published criteria. Paired outcomes were compared with McNemar's test; odds ratios (OR) and 95 % confidence intervals (CI) were computed from discordant pairs.

Results

On the MAIN-prompt dataset, the local RAG model identified CIMDL more often than the cloud comparator (discordant pairs: 44 [local-only] vs 19 [cloud-only]; χ2 with Yates correction = 9.14, p = 0.0025; OR = 2.28, 95 % CI 1.34–3.89).

Conclusions

Under realistic privacy constraints, a RAG-enabled local framework improved recognition of a key cancer mimicker during dental triage relative to a cloud LLM without retrieval.

Clinical relevance

Enhanced early recognition of CIMDL may prevent misclassification as oral SCC and expedite appropriate referral; local, privacy-preserving AI is feasible for chairside decision support.
目的测试本地托管的检索增强临床决策框架(CDF)与无检索的云大语言模型(LLM)相比,是否能提高牙科远程会诊期间可卡因诱导的中线破坏性病变(CIMDL)(一种恶性模拟物)的识别。材料和方法我们使用401次模拟咨询进行了配对可行性评估,这些咨询来自西格蒙德·弗洛伊德的历史病变叙述。本地CDF使用mistral-7b-instruct-v0.2与检索增强生成(RAG)对一个策划的CIMDL语料库;比较器采用gpt - 40访问,无需检索。两组使用了相同的提示和临床背景。主要终点是将CIMDL纳入鉴别诊断,根据已公布的标准进行判定。配对结果与McNemar检验进行比较;从不一致的对中计算比值比(OR)和95%置信区间(CI)。结果在MAIN-prompt数据集中,本地RAG模型识别CIMDL的频率高于云比较器(不一致对:44对[local-only] vs 19对[cloud-only]; χ2与Yates校正= 9.14,p = 0.0025; OR = 2.28, 95% CI 1.34-3.89)。结论:在现实的隐私约束下,相对于没有检索的云LLM, ragg支持的本地框架在牙科分诊过程中提高了对关键癌症模拟物的识别。临床相关性:加强对CIMDL的早期识别可以防止误诊为口腔SCC,并加快适当的转诊;本地的、保护隐私的人工智能对于主席决策支持是可行的。
{"title":"Artificial intelligence in oral cancer: a feasibility study informed by Freud's case","authors":"Michael Truppe ,&nbsp;Kurt Schicho ,&nbsp;Michael Figl ,&nbsp;Simone Holawe ,&nbsp;Christos Perisanidis","doi":"10.1016/j.oor.2025.100773","DOIUrl":"10.1016/j.oor.2025.100773","url":null,"abstract":"<div><h3>Objective</h3><div>To test whether a locally hosted, retrieval-augmented clinical decision framework (CDF) improves recognition of cocaine-induced midline destructive lesions (CIMDL)—a malignancy mimicker—during dental teleconsultation, compared with a cloud large language model (LLM) without retrieval.</div></div><div><h3>Materials and methods</h3><div>We conducted a paired feasibility evaluation using 401 simulated consultations derived from Sigmund Freud's historical lesion narrative. The local CDF used mistral-7b-instruct-v0.2 with retrieval-augmented generation (RAG) over a curated CIMDL corpus; the comparator was GPT-4o accessed without retrieval. Identical prompts and clinical context were used in both arms. The primary endpoint was inclusion of CIMDL in the differential diagnosis, adjudicated against published criteria. Paired outcomes were compared with McNemar's test; odds ratios (OR) and 95 % confidence intervals (CI) were computed from discordant pairs.</div></div><div><h3>Results</h3><div>On the MAIN-prompt dataset, the local RAG model identified CIMDL more often than the cloud comparator (discordant pairs: 44 [local-only] vs 19 [cloud-only]; χ<sup>2</sup> with Yates correction = 9.14, p = 0.0025; OR = 2.28, 95 % CI 1.34–3.89).</div></div><div><h3>Conclusions</h3><div>Under realistic privacy constraints, a RAG-enabled local framework improved recognition of a key cancer mimicker during dental triage relative to a cloud LLM without retrieval.</div></div><div><h3>Clinical relevance</h3><div>Enhanced early recognition of CIMDL may prevent misclassification as oral SCC and expedite appropriate referral; local, privacy-preserving AI is feasible for chairside decision support.</div></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":"17 ","pages":"Article 100773"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145712471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LeChat in oral pathology: Assessment of its immunohistochemical marker selection accuracy in salivary gland tumors 口腔病理学:涎腺肿瘤免疫组织化学标记物选择准确性评估
Pub Date : 2026-03-01 Epub Date: 2026-01-03 DOI: 10.1016/j.oor.2025.100781
Maria Cuevas-Nunez , Cosimo Galletti , Javier Flores-Fraile , Cosimo Galletti , Shokoufeh Shahrabi Farahani , Wilmer Rodrigo Díaz-Castañeda , Daniele Portelli , Luca Fiorillo , Vini Mehta , Maria-Teresa Fernández-Figueras

Background

Artificial intelligence (AI) is increasingly integrated into pathology, but its accuracy in immunohistochemical (IHC) marker selection remains underexplored. This study evaluated LeChat's ability to recommend IHC markers for benign and malignant salivary gland tumors, focusing on accuracy, completeness, relevance, consistency, and marker-level errors across tumor types and subtypes.

Methods

A total of 21 tumor types were selected and classified by behavior (benign vs. malignant) and histologic subtype. Expert-derived reference panels served as the gold standard. For each tumor, LeChat was queried three times using standardized prompts. Recommendations were scored across three domains: accuracy (inclusion of essential markers), completeness (inclusion of secondary markers), and relevance (absence of irrelevant markers). Composite scores (range: 3–9) and intra-tumor variability were calculated. Mann–Whitney U and Kruskal–Wallis tests assessed differences by tumor category and subtype. Marker-level analysis evaluated over- and under-recommendations.

Results

Across 63 total prompts, LeChat achieved a mean accuracy of 1.56, completeness of 1.59, and relevance of 2.35. Only 3.2 % of prompts included all essential markers, and 17.5 % achieved composite scores ≥7. No responses included both primary and secondary markers. Performance did not differ significantly between benign and malignant tumors (p = 0.405), nor across histologic subtypes (p = 0.988). Tumor-level variability was highest for basaloid squamous cell carcinoma and lowest for pleomorphic adenoma. Marker-level analysis identified 14 false positives (e.g., CD20, IgG4) and 9 false negatives (e.g., SOX10, β-catenin). A moderate correlation was observed between marker frequency and accuracy (r = 0.48, p < 0.01).

Conclusion

LeChat's IHC recommendations were generally relevant but frequently incomplete and inconsistent, particularly for malignant and histologically complex tumors. Despite its potential for assisting in straightforward cases, current performance remains inferior to expert standards. These findings highlight the limitations of general-purpose LLMs in pathology workflows and emphasize the need for domain-specific refinement before clinical integration.
人工智能(AI)越来越多地融入病理学,但其在免疫组织化学(IHC)标记物选择中的准确性仍未得到充分探索。本研究评估了LeChat推荐良性和恶性唾液腺肿瘤IHC标记物的能力,重点关注肿瘤类型和亚型的准确性、完整性、相关性、一致性和标记物水平误差。方法选择21种肿瘤类型,根据肿瘤的良、恶性行为和组织学亚型进行分类。专家衍生的参考小组作为黄金标准。对于每个肿瘤,LeChat使用标准化提示进行了三次查询。建议在三个领域进行评分:准确性(包括基本标记),完整性(包括次要标记)和相关性(没有无关标记)。计算综合评分(范围:3-9)和肿瘤内变异性。Mann-Whitney U和Kruskal-Wallis测试评估了肿瘤类型和亚型的差异。标志物水平分析评估了推荐值过高和不足。结果在总共63个提示中,LeChat的平均准确率为1.56,完整性为1.59,相关性为2.35。只有3.2%的提示包括所有基本标记,17.5%的提示达到综合得分≥7。没有反应包括主要和次要标记。良性和恶性肿瘤之间的表现无显著差异(p = 0.405),不同组织学亚型之间的表现也无显著差异(p = 0.988)。肿瘤水平变异在基底样鳞状细胞癌中最高,在多形性腺瘤中最低。标记水平分析鉴定出14个假阳性(如CD20、IgG4)和9个假阴性(如SOX10、β-catenin)。标记频率与准确性之间存在中度相关性(r = 0.48, p < 0.01)。结论lechat的免疫组化建议总体上是相关的,但往往是不完整和不一致的,特别是对于恶性和组织学复杂的肿瘤。尽管它有可能协助简单的案件,但目前的表现仍低于专家标准。这些发现强调了通用法学硕士在病理学工作流程中的局限性,并强调了在临床整合之前需要对特定领域进行细化。
{"title":"LeChat in oral pathology: Assessment of its immunohistochemical marker selection accuracy in salivary gland tumors","authors":"Maria Cuevas-Nunez ,&nbsp;Cosimo Galletti ,&nbsp;Javier Flores-Fraile ,&nbsp;Cosimo Galletti ,&nbsp;Shokoufeh Shahrabi Farahani ,&nbsp;Wilmer Rodrigo Díaz-Castañeda ,&nbsp;Daniele Portelli ,&nbsp;Luca Fiorillo ,&nbsp;Vini Mehta ,&nbsp;Maria-Teresa Fernández-Figueras","doi":"10.1016/j.oor.2025.100781","DOIUrl":"10.1016/j.oor.2025.100781","url":null,"abstract":"<div><h3>Background</h3><div>Artificial intelligence (AI) is increasingly integrated into pathology, but its accuracy in immunohistochemical (IHC) marker selection remains underexplored. This study evaluated LeChat's ability to recommend IHC markers for benign and malignant salivary gland tumors, focusing on accuracy, completeness, relevance, consistency, and marker-level errors across tumor types and subtypes.</div></div><div><h3>Methods</h3><div>A total of 21 tumor types were selected and classified by behavior (benign vs. malignant) and histologic subtype. Expert-derived reference panels served as the gold standard. For each tumor, LeChat was queried three times using standardized prompts. Recommendations were scored across three domains: accuracy (inclusion of essential markers), completeness (inclusion of secondary markers), and relevance (absence of irrelevant markers). Composite scores (range: 3–9) and intra-tumor variability were calculated. Mann–Whitney U and Kruskal–Wallis tests assessed differences by tumor category and subtype. Marker-level analysis evaluated over- and under-recommendations.</div></div><div><h3>Results</h3><div>Across 63 total prompts, LeChat achieved a mean accuracy of 1.56, completeness of 1.59, and relevance of 2.35. Only 3.2 % of prompts included all essential markers, and 17.5 % achieved composite scores ≥7. No responses included both primary and secondary markers. Performance did not differ significantly between benign and malignant tumors (p = 0.405), nor across histologic subtypes (p = 0.988). Tumor-level variability was highest for basaloid squamous cell carcinoma and lowest for pleomorphic adenoma. Marker-level analysis identified 14 false positives (e.g., CD20, IgG4) and 9 false negatives (e.g., SOX10, β-catenin). A moderate correlation was observed between marker frequency and accuracy (r = 0.48, p &lt; 0.01).</div></div><div><h3>Conclusion</h3><div>LeChat's IHC recommendations were generally relevant but frequently incomplete and inconsistent, particularly for malignant and histologically complex tumors. Despite its potential for assisting in straightforward cases, current performance remains inferior to expert standards. These findings highlight the limitations of general-purpose LLMs in pathology workflows and emphasize the need for domain-specific refinement before clinical integration.</div></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":"17 ","pages":"Article 100781"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adenomatoid odontogenic tumor mimicking nasal pathology: A case report on endoscopic endonasal management 模拟鼻病理的腺瘤样牙源性肿瘤:内镜下鼻内治疗一例报告
Pub Date : 2026-03-01 Epub Date: 2026-01-14 DOI: 10.1016/j.oor.2026.100783
Kawita Atipas , Sataporn Ruangprasertkul , Suvajana Atipas

Background

Adenomatoid odontogenic tumor (AOT) is a rare benign epithelial odontogenic tumor that typically occurs in young females and is most often associated with an impacted maxillary canine. Although usually managed via transoral enucleation, endoscopic endonasal surgery has emerged as a potential alternative for selected lesions.

Case presentation

A 25-year-old woman presented with progressive right-sided nasal obstruction and clear rhinorrhea. Nasal endoscopy revealed a smooth submucosal bulge arising from the right inferior meatus that filled the right nasal cavity. Computed tomography demonstrated a well-defined expansile lesion occupying the right maxillary sinus, containing internal calcifications and an impacted canine tooth. The tumor was completely removed using an endoscopic endonasal approach. Histopathology confirmed the diagnosis of AOT. At the 18-month follow-up, endoscopic examination showed complete healing without recurrence.

Discussion

Endoscopic endonasal surgery offers advantages over transoral approaches in selected cases, including improved visualization, avoidance of oroantral complications, absence of external incisions, and suitability for large maxillary sinus lesions.

Conclusion

This case demonstrates the feasibility of complete AOT removal using an endoscopic endonasal approach. Further reports with long-term follow-up are required to clarify indications and outcomes for this technique.
背景:腺瘤样牙源性肿瘤(AOT)是一种罕见的良性上皮性牙源性肿瘤,通常发生在年轻女性中,最常与上颌犬阻生有关。虽然通常通过经口去核,内镜鼻内手术已成为一个潜在的替代选择病变。病例表现一名25岁女性,表现为进行性右侧鼻塞和明显的鼻漏。鼻内窥镜显示光滑的粘膜下隆起,起源于右下鼻道,充满右鼻腔。计算机断层扫描显示右侧上颌窦有明确的扩张病灶,包含内部钙化和阻生犬牙。经内镜鼻内入路完全切除肿瘤。组织病理学证实AOT的诊断。在18个月的随访中,内镜检查显示完全愈合,无复发。内镜下鼻内手术在某些情况下比经口入路有优势,包括更好的可视化,避免口窦并发症,没有外部切口,适合较大的上颌窦病变。结论本病例证明经鼻内镜入路完全切除AOT的可行性。需要长期随访的进一步报告来阐明该技术的适应症和结果。
{"title":"Adenomatoid odontogenic tumor mimicking nasal pathology: A case report on endoscopic endonasal management","authors":"Kawita Atipas ,&nbsp;Sataporn Ruangprasertkul ,&nbsp;Suvajana Atipas","doi":"10.1016/j.oor.2026.100783","DOIUrl":"10.1016/j.oor.2026.100783","url":null,"abstract":"<div><h3>Background</h3><div>Adenomatoid odontogenic tumor (AOT) is a rare benign epithelial odontogenic tumor that typically occurs in young females and is most often associated with an impacted maxillary canine. Although usually managed via transoral enucleation, endoscopic endonasal surgery has emerged as a potential alternative for selected lesions.</div></div><div><h3>Case presentation</h3><div>A 25-year-old woman presented with progressive right-sided nasal obstruction and clear rhinorrhea. Nasal endoscopy revealed a smooth submucosal bulge arising from the right inferior meatus that filled the right nasal cavity. Computed tomography demonstrated a well-defined expansile lesion occupying the right maxillary sinus, containing internal calcifications and an impacted canine tooth. The tumor was completely removed using an endoscopic endonasal approach. Histopathology confirmed the diagnosis of AOT. At the 18-month follow-up, endoscopic examination showed complete healing without recurrence.</div></div><div><h3>Discussion</h3><div>Endoscopic endonasal surgery offers advantages over transoral approaches in selected cases, including improved visualization, avoidance of oroantral complications, absence of external incisions, and suitability for large maxillary sinus lesions.</div></div><div><h3>Conclusion</h3><div>This case demonstrates the feasibility of complete AOT removal using an endoscopic endonasal approach. Further reports with long-term follow-up are required to clarify indications and outcomes for this technique.</div></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":"17 ","pages":"Article 100783"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 66-year-old female patient with folliculoma metastasis to cervical lymph nodes. Case report 66岁女性患者,滤泡瘤转移至颈部淋巴结。病例报告
Pub Date : 2026-03-01 Epub Date: 2025-12-16 DOI: 10.1016/j.oor.2025.100778
Klementyna Dmowska , Nikola Leszczyńska , Piotr Nogal , Małgorzata Leszczyńska , Mariusz Kasprzyk , Mateusz Banaszewski , Jacek Banaszewski
Correct diagnosis of cervical cystic lesion might prove difficult - while in most cases those are benign, malignant diseases must be taken into consideration. We would like to present a case of a 66-year-old female patient with folliculoma metastasis to cervical lymph nodes - primarily recognised as branchial cleft cyst.
宫颈囊性病变的正确诊断可能是困难的,而在大多数情况下,这些是良性的,必须考虑到恶性疾病。我们想提出一个66岁的女性患者的情况下,滤泡瘤转移到颈部淋巴结-主要被认为是鳃裂囊肿。
{"title":"A 66-year-old female patient with folliculoma metastasis to cervical lymph nodes. Case report","authors":"Klementyna Dmowska ,&nbsp;Nikola Leszczyńska ,&nbsp;Piotr Nogal ,&nbsp;Małgorzata Leszczyńska ,&nbsp;Mariusz Kasprzyk ,&nbsp;Mateusz Banaszewski ,&nbsp;Jacek Banaszewski","doi":"10.1016/j.oor.2025.100778","DOIUrl":"10.1016/j.oor.2025.100778","url":null,"abstract":"<div><div>Correct diagnosis of cervical cystic lesion might prove difficult - while in most cases those are benign, malignant diseases must be taken into consideration. We would like to present a case of a 66-year-old female patient with folliculoma metastasis to cervical lymph nodes - primarily recognised as branchial cleft cyst.</div></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":"17 ","pages":"Article 100778"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145792004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of molecular driver mutations in recurrence of early-stage laryngeal cancer following narrow field definitive radiotherapy 分子驱动突变在早期喉癌窄场放射治疗后复发中的作用
Pub Date : 2026-03-01 Epub Date: 2025-12-17 DOI: 10.1016/j.oor.2025.100780
D. Morgan , E. Schueddig , A. Segura , T. Bodine , C. Lominska , R.T. Morse , P. Neupane , D. Pei , D. Koestler , R. Kimple , U. Duvvuri , S. Thomas , R. Nallani , L. Shnayder , K. Kakarala , A.M. Bur , E. Yilmaz , G.N. Gan

Purpose

Recurrence in early-stage laryngeal carcinoma after radiation therapy often necessitates a total salvage laryngectomy (TSL). Understanding the genetic landscape that influences cancer progression after radiation therapy may help future treatments. We investigated early-stage laryngeal carcinoma patients treated with radiotherapy to identify mutation patterns that predispose to disease recurrence.

Methods

The patient cohort had 35 early-stage laryngeal head and neck squamous cell carcinoma (HNSCC) patients (T1 = 15, T2 = 20) treated with radiotherapy (RT). We stratified patients: Responders (no recurrence, N = 14), non-responders (recurrence within 12 months, N = 21), and non-responders undergoing TSL (N = 18). We employed whole exome sequencing to characterize gene mutations using the Genome Analysis Toolkit (GATK) for variant detection and impact on critical biological pathways and post-radiotherapy patient outcomes. Pathway analysis Ingenuity and Reactome Pathway Analysis tools were used to explore the mutated gene pathways.

Results

– Differential mutation analysis was performed in the respective groups to find driver genes. In the pre-treatment samples, KCNT2 and AGAP6 mutations were exclusively found in non-responders (OR = 0, P = 0.005 and OR = 0, P = 0.027, respectively), while ADAMTS7 mutations were solely present in responders (OR = inf, P = 0.019). PLEC mutations were more prevalent in responders (OR = 11.6, P = 0.006). Pathway analysis revealed that significant genes were involved in the RND2 GTPase cycle, protein O-glycosylation-related diseases, and apoptotic pathways. Post-treatment analysis in patients undergoing TSL had enrichment of mutations in apoptosis regulation pathways.

Conclusions

– The study reveals that mutations in apoptosis controlling genes were predominantly represented in the larynx non-responder patients both in the pre-radiotherapy and post-TSL populations.
目的早期喉癌放射治疗后复发往往需要全喉切除术(TSL)。了解影响放射治疗后癌症进展的基因景观可能有助于未来的治疗。我们调查了早期喉癌放疗患者,以确定易导致疾病复发的突变模式。方法35例早期喉头颈部鳞状细胞癌(HNSCC)患者(T1 = 15, T2 = 20)行放射治疗(RT)。我们对患者进行了分层:反应者(无复发,N = 14),无反应者(12个月内复发,N = 21),以及接受TSL的无反应者(N = 18)。我们采用全外显子组测序来表征基因突变,使用基因组分析工具包(GATK)进行变异检测和对关键生物学途径和放疗后患者预后的影响。通路分析使用Ingenuity和Reactome通路分析工具探索突变基因通路。结果-在各自的组中进行差异突变分析以寻找驱动基因。在预处理样本中,KCNT2和AGAP6突变仅存在于无应答者中(OR = 0, P = 0.005和OR = 0, P = 0.027),而ADAMTS7突变仅存在于应答者中(OR = inf, P = 0.019)。应答者中PLEC突变更为普遍(OR = 11.6, P = 0.006)。通路分析显示,重要基因参与RND2 GTPase循环、蛋白o糖基化相关疾病和凋亡通路。TSL患者治疗后分析细胞凋亡调控通路突变富集。结论-该研究表明,在放疗前和tsl后的喉部无反应患者中,细胞凋亡控制基因的突变主要代表。
{"title":"Role of molecular driver mutations in recurrence of early-stage laryngeal cancer following narrow field definitive radiotherapy","authors":"D. Morgan ,&nbsp;E. Schueddig ,&nbsp;A. Segura ,&nbsp;T. Bodine ,&nbsp;C. Lominska ,&nbsp;R.T. Morse ,&nbsp;P. Neupane ,&nbsp;D. Pei ,&nbsp;D. Koestler ,&nbsp;R. Kimple ,&nbsp;U. Duvvuri ,&nbsp;S. Thomas ,&nbsp;R. Nallani ,&nbsp;L. Shnayder ,&nbsp;K. Kakarala ,&nbsp;A.M. Bur ,&nbsp;E. Yilmaz ,&nbsp;G.N. Gan","doi":"10.1016/j.oor.2025.100780","DOIUrl":"10.1016/j.oor.2025.100780","url":null,"abstract":"<div><h3>Purpose</h3><div>Recurrence in early-stage laryngeal carcinoma after radiation therapy often necessitates a total salvage laryngectomy (TSL). Understanding the genetic landscape that influences cancer progression after radiation therapy may help future treatments. We investigated early-stage laryngeal carcinoma patients treated with radiotherapy to identify mutation patterns that predispose to disease recurrence.</div></div><div><h3>Methods</h3><div>The patient cohort had 35 early-stage laryngeal head and neck squamous cell carcinoma (HNSCC) patients (T1 = 15, T2 = 20) treated with radiotherapy (RT). We stratified patients: Responders (no recurrence, N = 14), non-responders (recurrence within 12 months, N = 21), and non-responders undergoing TSL (N = 18). We employed whole exome sequencing to characterize gene mutations using the Genome Analysis Toolkit (GATK) for variant detection and impact on critical biological pathways and post-radiotherapy patient outcomes. Pathway analysis Ingenuity and Reactome Pathway Analysis tools were used to explore the mutated gene pathways.</div></div><div><h3>Results</h3><div>– Differential mutation analysis was performed in the respective groups to find driver genes. In the pre-treatment samples, KCNT2 and AGAP6 mutations were exclusively found in non-responders (OR = 0, P = 0.005 and OR = 0, P = 0.027, respectively), while ADAMTS7 mutations were solely present in responders (OR = inf, P = 0.019). PLEC mutations were more prevalent in responders (OR = 11.6, P = 0.006). Pathway analysis revealed that significant genes were involved in the RND2 GTPase cycle, protein O-glycosylation-related diseases, and apoptotic pathways. Post-treatment analysis in patients undergoing TSL had enrichment of mutations in apoptosis regulation pathways.</div></div><div><h3>Conclusions</h3><div>– The study reveals that mutations in apoptosis controlling genes were predominantly represented in the larynx non-responder patients both in the pre-radiotherapy and post-TSL populations.</div></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":"17 ","pages":"Article 100780"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HER3 and HPV in head and neck squamous cell carcinoma: Potential implications of induction chemotherapy on tumor immune microenvironment 头颈部鳞状细胞癌中HER3和HPV:诱导化疗对肿瘤免疫微环境的潜在影响
Pub Date : 2026-03-01 Epub Date: 2026-01-08 DOI: 10.1016/j.oor.2026.100782
Joori Kim , Jeong-Oh Kim , Youn Soo Lee , Jung-Young Shin , Min Young Kim , Mi-Ran Lee , Seoree Kim , Saori Fujita-Sato , Maki Kobayashi , Tomoya Kakegawa , Jin Hyoung Kang

Background

Receptor tyrosine-protein kinase erbB-3 (HER3) is frequently overexpressed in head and neck squamous cell carcinoma (HNSCC) and is typically associated with chemotherapy resistance and poor prognosis. However, the dynamics of HER3 expression following induction chemotherapy (ICT) remain poorly understood, and its impact on the tumor immune microenvironment (TIME) is largely unknown.

Methods

We analyzed 98 patients with locally advanced HNSCC who received ICT between 2012 and 2020. HER3 immunohistochemistry (IHC) was performed using the D22C5 clone on formalin-fixed paraffin-embedded specimens collected pre- and/or post-ICT. HPV status was determined for all samples. Compositional changes in immune cell subsets within the tumor and peritumoral areas were evaluated via multiplex IHC.

Results

The cohort (mean age: 62.9 years; 83.3 % male) predominantly presented with stage III or IV disease (97.2 %). The oropharynx was the most common primary site (66.7 %), with 52.8 % of patients being HPV-positive. High HER3 expression (H-score >100) strongly correlated with HPV positivity (p = 0.005), particularly within oropharyngeal tumors (p = 0.003). The objective response rate (ORR) to ICT was higher in the HER3-high group compared to the HER3-low group (87 % vs. 69 %; p = 0.090), a trend consistent with HPV status (p = 0.090). In 16 paired samples, HER3 expression increased post-ICT, most notably among smokers. Patients with high HER3 expression tended to have longer relapse-free survival and improved overall survival (76.3 vs. 42.4 months; p = 0.168) compared to those with low HER3 expression. At baseline, the tumor immune microenvironment (TIME) of HER3-high tumors was significantly enriched with CD4+FoxP3+ regulatory T cells (Tregs), compared to HER3-low tumors (p = 0.032). Post-ICT, HER3-high tumors exhibited a marked depletion of Tregs (p = 0.019), while CD8+ cytotoxic T cells increased significantly across all groups (p < 0.01). Finally, external validation using TCGA-HNSCC database confirmed that HER3 mRNA expression is positively associated with Tregs enrichment, independent of HPV status.

Conclusion

High HER3 expression in HNSCC is significantly associated with HPV positivity and predicts favorable clinical outcomes following ICT. Our findings suggest that ICT modulates the TIME by depleting immunosuppressive CD4+FoxP3+ Tregs specifically in HER3-high tumors while simultaneously recruiting immunostimulatory CD8+ T cells regardless of HER3 expression. This shift potentially converts an immunosuppressive environment into an immunostimulatory one.
背景:受体酪氨酸蛋白激酶erbB-3 (HER3)在头颈部鳞状细胞癌(HNSCC)中经常过表达,并且通常与化疗耐药和不良预后相关。然而,诱导化疗(ICT)后HER3表达的动态仍然知之甚少,其对肿瘤免疫微环境(TIME)的影响在很大程度上是未知的。方法对2012 ~ 2020年接受ICT治疗的98例局部晚期HNSCC患者进行分析。使用D22C5克隆对ict前后采集的福尔马林固定石蜡包埋标本进行HER3免疫组化(IHC)。检测所有样本的HPV状态。通过多重免疫组化评估肿瘤和肿瘤周围区域免疫细胞亚群的组成变化。结果该队列患者平均年龄62.9岁,男性83.3%,主要表现为III期或IV期疾病(97.2%)。口咽是最常见的原发部位(66.7%),其中52.8%的患者为hpv阳性。HER3高表达(H-score >100)与HPV阳性呈正相关(p = 0.005),特别是在口咽肿瘤中(p = 0.003)。her3高组对ICT的客观缓解率(ORR)高于her3低组(87%比69%,p = 0.090),这一趋势与HPV状态一致(p = 0.090)。在16个配对样本中,HER3表达在ict后增加,尤其是在吸烟者中。与HER3低表达的患者相比,HER3高表达的患者往往具有更长的无复发生存期和改善的总生存期(76.3个月对42.4个月;p = 0.168)。基线时,与her3低的肿瘤相比,her3高的肿瘤免疫微环境(TIME)中CD4+FoxP3+调节性T细胞(Tregs)显著富集(p = 0.032)。ict后,her3高的肿瘤表现出明显的Tregs缺失(p = 0.019),而CD8+细胞毒性T细胞在所有组中均显著增加(p < 0.01)。最后,使用TCGA-HNSCC数据库进行外部验证,证实her3mrna表达与Tregs富集呈正相关,与HPV状态无关。结论HER3在HNSCC中高表达与HPV阳性显著相关,并预示着ICT后良好的临床预后。我们的研究结果表明,在HER3高的肿瘤中,ICT通过特异性地消耗免疫抑制性CD4+FoxP3+ Tregs来调节TIME,同时招募免疫刺激性CD8+ T细胞,而不管HER3的表达如何。这种转变可能将免疫抑制环境转化为免疫刺激环境。
{"title":"HER3 and HPV in head and neck squamous cell carcinoma: Potential implications of induction chemotherapy on tumor immune microenvironment","authors":"Joori Kim ,&nbsp;Jeong-Oh Kim ,&nbsp;Youn Soo Lee ,&nbsp;Jung-Young Shin ,&nbsp;Min Young Kim ,&nbsp;Mi-Ran Lee ,&nbsp;Seoree Kim ,&nbsp;Saori Fujita-Sato ,&nbsp;Maki Kobayashi ,&nbsp;Tomoya Kakegawa ,&nbsp;Jin Hyoung Kang","doi":"10.1016/j.oor.2026.100782","DOIUrl":"10.1016/j.oor.2026.100782","url":null,"abstract":"<div><h3>Background</h3><div>Receptor tyrosine-protein kinase erbB-3 (HER3) is frequently overexpressed in head and neck squamous cell carcinoma (HNSCC) and is typically associated with chemotherapy resistance and poor prognosis. However, the dynamics of HER3 expression following induction chemotherapy (ICT) remain poorly understood, and its impact on the tumor immune microenvironment (TIME) is largely unknown.</div></div><div><h3>Methods</h3><div>We analyzed 98 patients with locally advanced HNSCC who received ICT between 2012 and 2020. HER3 immunohistochemistry (IHC) was performed using the D22C5 clone on formalin-fixed paraffin-embedded specimens collected pre- and/or post-ICT. HPV status was determined for all samples. Compositional changes in immune cell subsets within the tumor and peritumoral areas were evaluated via multiplex IHC.</div></div><div><h3>Results</h3><div>The cohort (mean age: 62.9 years; 83.3 % male) predominantly presented with stage III or IV disease (97.2 %). The oropharynx was the most common primary site (66.7 %), with 52.8 % of patients being HPV-positive. High HER3 expression (H-score &gt;100) strongly correlated with HPV positivity (p = 0.005), particularly within oropharyngeal tumors (p = 0.003). The objective response rate (ORR) to ICT was higher in the HER3-high group compared to the HER3-low group (87 % vs. 69 %; p = 0.090), a trend consistent with HPV status (p = 0.090). In 16 paired samples, HER3 expression increased post-ICT, most notably among smokers. Patients with high HER3 expression tended to have longer relapse-free survival and improved overall survival (76.3 vs. 42.4 months; p = 0.168) compared to those with low HER3 expression. At baseline, the tumor immune microenvironment (TIME) of HER3-high tumors was significantly enriched with CD4<sup>+</sup>FoxP3<sup>+</sup> regulatory T cells (Tregs), compared to HER3-low tumors (p = 0.032). Post-ICT, HER3-high tumors exhibited a marked depletion of Tregs (p = 0.019), while CD8<sup>+</sup> cytotoxic T cells increased significantly across all groups (p &lt; 0.01). Finally, external validation using TCGA-HNSCC database confirmed that HER3 mRNA expression is positively associated with Tregs enrichment, independent of HPV status.</div></div><div><h3>Conclusion</h3><div>High HER3 expression in HNSCC is significantly associated with HPV positivity and predicts favorable clinical outcomes following ICT. Our findings suggest that ICT modulates the TIME by depleting immunosuppressive CD4<sup>+</sup>FoxP3<sup>+</sup> Tregs specifically in HER3-high tumors while simultaneously recruiting immunostimulatory CD8<sup>+</sup> T cells regardless of HER3 expression. This shift potentially converts an immunosuppressive environment into an immunostimulatory one.</div></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":"17 ","pages":"Article 100782"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146173448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic implication of the expression of minichromosome maintenance protein 5 (MCM 5) in oral cavity squamous cell carcinomas-a study on cases from a tertiary care centre 小染色体维持蛋白5 (mcm5)在口腔鳞状细胞癌中表达的预后意义——一项来自三级保健中心的病例研究
Pub Date : 2026-03-01 Epub Date: 2026-02-25 DOI: 10.1016/j.oor.2026.100786
Monica Charlotte Solomon, Chetana Chandrashekar, Priya Sharma, Pavithra Veluswamy

Background

Minichromosome maintenance (MCM) proteins play a vital role in cell cycle progression. The MCM 5 protein is one of the key proteins that binds to Chromatin in a cell cycle dependent manner and restricts the replication of the chromosome to only one round per cell cycle.

Objectives

To evaluate the role of MCM5 in the biological behavior of Oral Cavity Squamous cell carcinomas of patients from a tertiary care centre.

Method

This study evaluated the immunohistochemical expression of MCM-5 protein in primary oral squamous cell carcinomas(n = 90). Formalin Fixed Paraffin Embedded tissue (FFPE) sections of the tumors were immunhistochemically stained with the monoclonal antibody MCM-5 (EP-84, Pathnsitu, Livermore, CA, USA). The correlation between the expression of MCM5 and clinico-pathological features of the dysplastic lesions and oral squamous cell carcinoma tumors was analysed. The association between the expression of MCM5 and patient outcomes was also evaluated.

Results

The mean nuclear MCM5 LI for the 90 cases of OSCC ranged from 0 to 90 (mean 52.88 +- 2.084). A higher mean nuclear MCM5 LI was associated with the higher histological tumor grade (p = 0.002). Tumors of an advanced clinical stage had a higher mean nuclear MCM5 LI compared to tumors of an early clinical stage (p = 0.039)

Conclusions

The MCM-5 protein is a key molecule that is altered during the carcinogenic process of squamous cell carcinomas of the oral cavity. A higher expression of MCM5 is indicative of aggressive tumor behaviour of oral cavity squamous cell carcinomas.
小染色体维持蛋白(MCM)在细胞周期进程中起着至关重要的作用。mcm5蛋白是以细胞周期依赖的方式与染色质结合的关键蛋白之一,并将染色体的复制限制在每个细胞周期只有一轮。目的评价MCM5在某三级保健中心口腔鳞状细胞癌患者的生物学行为中的作用。方法观察90例原发性口腔鳞状细胞癌组织中MCM-5蛋白的免疫组化表达。用单克隆抗体MCM-5 (EP-84, Pathnsitu, Livermore, CA, USA)对肿瘤的福尔马林固定石蜡包埋组织(FFPE)切片进行免疫组织化学染色。分析MCM5表达与口腔发育不良病变及口腔鳞状细胞癌临床病理特征的相关性。还评估了MCM5表达与患者预后之间的关系。结果90例OSCC的核MCM5 LI平均值为0 ~ 90(52.88±2.084)。较高的核MCM5 LI与较高的组织学肿瘤分级相关(p = 0.002)。结论MCM-5蛋白是口腔鳞状细胞癌在癌变过程中发生改变的关键分子。MCM5的高表达表明口腔鳞状细胞癌具有侵袭性肿瘤行为。
{"title":"Prognostic implication of the expression of minichromosome maintenance protein 5 (MCM 5) in oral cavity squamous cell carcinomas-a study on cases from a tertiary care centre","authors":"Monica Charlotte Solomon,&nbsp;Chetana Chandrashekar,&nbsp;Priya Sharma,&nbsp;Pavithra Veluswamy","doi":"10.1016/j.oor.2026.100786","DOIUrl":"10.1016/j.oor.2026.100786","url":null,"abstract":"<div><h3>Background</h3><div>Minichromosome maintenance (MCM) proteins play a vital role in cell cycle progression. The MCM 5 protein is one of the key proteins that binds to Chromatin in a cell cycle dependent manner and restricts the replication of the chromosome to only one round per cell cycle.</div></div><div><h3>Objectives</h3><div>To evaluate the role of MCM5 in the biological behavior of Oral Cavity Squamous cell carcinomas of patients from a tertiary care centre.</div></div><div><h3>Method</h3><div>This study evaluated the immunohistochemical expression of MCM-5 protein in primary oral squamous cell carcinomas(n = 90). Formalin Fixed Paraffin Embedded tissue (FFPE) sections of the tumors were immunhistochemically stained with the monoclonal antibody MCM-5 (EP-84, Pathnsitu, Livermore, CA, USA). The correlation between the expression of MCM5 and clinico-pathological features of the dysplastic lesions and oral squamous cell carcinoma tumors was analysed. The association between the expression of MCM5 and patient outcomes was also evaluated.</div></div><div><h3>Results</h3><div>The mean nuclear MCM5 LI for the 90 cases of OSCC ranged from 0 to 90 (mean 52.88 +- 2.084). A higher mean nuclear MCM5 LI was associated with the higher histological tumor grade (p = 0.002). Tumors of an advanced clinical stage had a higher mean nuclear MCM5 LI compared to tumors of an early clinical stage (p = 0.039)</div></div><div><h3>Conclusions</h3><div>The MCM-5 protein is a key molecule that is altered during the carcinogenic process of squamous cell carcinomas of the oral cavity. A higher expression of MCM5 is indicative of aggressive tumor behaviour of oral cavity squamous cell carcinomas.</div></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":"17 ","pages":"Article 100786"},"PeriodicalIF":0.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147385009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Oral Oncology Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1